EUVIMEDOpdag EUVIMED
Zurückgezogene Publikation

The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma

Nabil M Abdel-Hamid, Sherin M Zakaria, Abeer M Ansary, Fardous F El-Senduny, Mamdouh M El-Shishtawy

Cell Biochemistry and Function · 2023-10 · 41 (7) · 788-800

DOI: 10.1002/cbf.3828 ↗

At a glance

Zurückgezogene Publikation in Cell Biochemistry and Function, published online on 2023-07-20. Written by Nabil M Abdel-Hamid and 4 co-authors. Institution: Department of Biochemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms. 44 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Currently, many challenges are associated with hepatocellular carcinoma (HCC) as the failure of early diagnosis, and the lack of effective therapy. This study aimed to investigate the possible role of tuftelin 1 (TUFT 1) in the early diagnosis of HCC and evaluate the potential contribution of the TUFT 1/Ca +2 /phosphinositol 3 kinase (PI3K) pathway in dantrolene sodium (Dan) therapeutic outcomes. The study was performed on two sets of rats, the staging (30 rats) and treatment sets (80 rats). HCC was induced by a single dose of diethylnitrosamine (DENA). The hepatic content of TUFT 1 protein was assayed via western blot and immunohistochemistry (IHC), while PI3K, vascular endothelial growth factor (VEGF), Cyclin D1, and matrix‐metalloproteinase‐9 (MMP‐9) contents were assessed using enzyme‐linked immunosorbent assay. Hepatic and serum calcium were measured colorimetrically. Furthermore, the nuclear proliferation marker, (Ki‐67), (Kiel [Ki] where the antibody was produced in the University Department of Pathology and the original clone number is 67)—expression was assessed by IHC. TUFT 1/Ca +2 /PI3K signaling pathway was progressively activated in the 3 studied stages of HCC with subsequent upregulation of angiogenesis, cell cycle, and metastasis. More interestingly, Dan led to TUFT 1/Ca +2 /PI3K pathway disruption by diminution of the hepatic contents of TUFT 1, calcium, PI3K, VEGF, Cyclin D1, and MMP‐9 in a dose‐dependent pattern. TUFT 1 can serve as a theranostic biomarker in HCC. Moreover, Dan exerted an antineoplastic effect against HCC via the interruption of TUFT 1/Ca +2 /PI3K pathway.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansRatsAnimalsMatrix Metalloproteinase 9Vascular Endothelial Growth Factor ACyclin D1Phosphatidylinositol 3-KinasesPrecision MedicineCalciumProto-Oncogene Proteins c-aktEarly DiagnosisCell ProliferationCell Line, TumorDental Enamel Proteins

Author keywords

HCCPI3KTUFT 1dantrolene sodiummetastasistheranosis

Substances

Matrix Metalloproteinase 9Vascular Endothelial Growth Factor ACyclin D1Phosphatidylinositol 3-KinasesCalciumProto-Oncogene Proteins c-akttuftelinDental Enamel Proteins

Authors and institutions

  • Department of Biochemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
  • Department of Chemistry (Biochemistry Division), Faculty of Science, Mansoura University, Mansoura, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Cite

APA

Abdel-Hamid, N. M., Zakaria, S. M., Ansary, A. M., El-Senduny, F. F., & El-Shishtawy, M. M. (2023). The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma. Cell Biochemistry and Function, 41(7), 788-800. https://doi.org/10.1002/cbf.3828

Vancouver

Abdel-Hamid NM, Zakaria SM, Ansary AM, El-Senduny FF, El-Shishtawy MM. The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma. Cell Biochemistry and Function. 2023;41(7):788-800. doi:10.1002/cbf.3828

BibTeX
@article{AbdelHamid2023,
  author = {Abdel-Hamid, Nabil M and Zakaria, Sherin M and Ansary, Abeer M and El-Senduny, Fardous F and El-Shishtawy, Mamdouh M},
  title = {The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma},
  journal = {Cell Biochemistry and Function},
  year = {2023},
  volume = {41},
  number = {7},
  pages = {788--800},
  doi = {10.1002/cbf.3828}
}
Start for free →